![](/img/cover-not-exists.png)
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin’s lymphoma
R. García-Sanz, T.J. González-López, L. Vázquez, G. Hermida, I.F. Graciani, J.F. San MiguelVolume:
84
Year:
2010
Language:
english
Pages:
5
DOI:
10.1111/j.1600-0609.2009.01375.x
File:
PDF, 176 KB
english, 2010